MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Ginkgo Technology Network Launches, Providing an Integrated R&D

GoodRx debuts a new e-commerce platform, starting with Opill®

31 Oct 2024

GoodRx the leading prescription savings platform in the U.S., announced the rollout of its new...

Newly-formed Archerfish Precision Diagnostics Pte Ltd ushers in a new era in advanced diagnostics

Xencor Announces Promising Early Results for XmAb942 in First-in-Human Study Targeting IBD

Redefining Pharmaceutical Market Analytics and Insights: PharmaScroll

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

By Alteogen Inc.
Alteogen Inc.
17 Sep 2025

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

By Sanguine Biosciences
Sanguine Biosciences
17 Sep 2025

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

By Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc.
16 Sep 2025

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

By Novocure
Novocure
16 Sep 2025

At the American Thyroid Association meeting, FORE Biotherapeutics presented Phase 1/2a data for Plixorafenib, demonstrating a prolonged duration of effect in BRAF-altered thyroid cancers

By FORE Biotherapeutics
FORE Biotherapeutics
15 Sep 2025

At the PHPN 2025 Symposium, Corsair Pharma will present new data on its proprietary transdermal system for Treprostinil prodrug

By Corsair Pharma
Corsair Pharma
15 Sep 2025

Pharmaceutical

9th Edition International Conference on Drug Discovery and Lead Optimization

06 Oct 2025 10:00 am - 08 Oct 2025 5:30 pm

Houston TX

Most Popular

SciTech Development reveals promising Phase 1A trial results for T-cell non-Hodgkin lymphoma therapy

By SciTech Development, Inc

Dec 03
China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

By Puyi (Shanghai) Biotechnology Co., Ltd

Aug 23
Zafrens expands its investor syndicate to scale its revolutionary drug discovery platform

By Zafrens

Feb 04

September 2025

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Ginkgo Technology Network Launches, Providing an Integrated R&D

GoodRx debuts a new e-commerce platform, starting with Opill®

Newly-formed Archerfish Precision Diagnostics Pte Ltd ushers in a new era in advanced diagnostics

Xencor Announces Promising Early Results for XmAb942 in First-in-Human Study Targeting IBD

Redefining Pharmaceutical Market Analytics and Insights: PharmaScroll

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

European Commission Approves Alteogen’s Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

At the American Thyroid Association meeting, FORE Biotherapeutics presented Phase 1/2a data for Plixorafenib, demonstrating a prolonged duration of effect in BRAF-altered thyroid cancers

At the PHPN 2025 Symposium, Corsair Pharma will present new data on its proprietary transdermal system for Treprostinil prodrug

Most Popular

SciTech Development reveals promising Phase 1A trial results for T-cell non-Hodgkin lymphoma therapy

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

Zafrens expands its investor syndicate to scale its revolutionary drug discovery platform

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe for e-Newsletter Monthly